SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested to fight Tough-to-Treat cancers
Disease control CompletedThis study tested the safety and effectiveness of combining two drugs, lenvatinib and eribulin, for treating advanced liposarcoma and leiomyosarcoma. It involved 30 patients whose cancer could not be surgically removed or had spread, and who had received up to two prior chemother…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt for clues to match sarcoma patients with treatment
Knowledge-focused CompletedThis study aimed to find biological markers that could predict which patients with advanced soft-tissue sarcoma would respond well to the drug trabectedin. Researchers collected tumor and blood samples from 29 adult patients before, during, and after treatment to analyze their ge…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC